| Thromboembolism |
1 |
1 |
| Aspirin |
0 |
0.99 |
| Arthroplasty |
0 |
0.66 |
| Prophylaxis |
0 |
0.95 |
| Hospital Medicine |
0 |
0.9 |
| Deep Venous Thrombosis |
0 |
0.29 |
| Pulmonary Embolism |
0 |
0.26 |
| Hospital |
0 |
0.22 |
| Virginia |
0 |
0.22 |
| Anticoagulation Therapy |
0 |
0.16 |
| Meta-Analysis |
0 |
0.16 |
| Venous Thromboembolism (VTE) |
0 |
0.96 |
| Myocardial Infarction (MI) |
0 |
0.12 |
| Total Hip Arthroplasty |
0 |
0.85 |
| Clinical Research |
0 |
0.05 |
| Embolism |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Hip Replacement |
0 |
0.05 |
| Internship |
0 |
0.05 |
| Low-Molecular-Weight Heparin |
0 |
0.05 |
| Myocardial Infarction (MI) Complication |
0 |
0.05 |
| Thorax |
0 |
0.05 |
| Thrombosis |
0 |
0.05 |
| Total Knee Arthroplasty |
0 |
0.8 |
| Vein |
0 |
0.05 |